Sorrento Resources Announces Listed Issuer Financing Exemption (LIFE) Non-Brokered Private Placement
aTyr PharmaaTyr Pharma(US:LIFE) TMX Newsfile·2026-02-04 10:30

Core Viewpoint - Sorrento Resources Ltd. is conducting a non-brokered private placement to raise up to CDN$2,000,000 through the issuance of 8,000,000 units at CDN$0.25 per unit [1]. Group 1: Offering Details - Each unit consists of one common share and one common share purchase warrant, with the warrant exercisable at $0.35 per share for 24 months from closing [2]. - The offering is being conducted under the LIFE Exemption, allowing it to be offered to purchasers in all Canadian provinces except Quebec, with no hold period for the issued units [3]. - The company may pay a finder's fee of up to 6% of the gross proceeds and issue non-transferable warrants equal to 6% of the units sold, also exercisable at $0.35 [4]. Group 2: Use of Proceeds and Closing - The net proceeds from the offering will be allocated for exploration expenditures, marketing, promotion, and general working capital [5]. - The offering is expected to close on or about February 27, 2026, subject to necessary approvals, including from the Canadian Securities Exchange [5]. Group 3: Company Overview - Sorrento Resources Ltd. focuses on the acquisition, exploration, and development of mineral properties in Canada, including projects like Bottom Brook, Rodgers Cove Gold, and Harmsworth [7].

aTyr Pharma-Sorrento Resources Announces Listed Issuer Financing Exemption (LIFE) Non-Brokered Private Placement - Reportify